SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • December 3rd, 2012 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledDecember 3rd, 2012 Company Industry JurisdictionThis Securities Exchange Agreement (as amended, restated, supplemented or otherwise modified, this “Agreement”) is dated as of November 27, 2012 and is entered into by and between NAVIDEA BIOPHARMACEUTICALS, INC. (the “Company”), and PLATINUM PARTNERS VALUE ARBITRAGE FUND, L.P. (“Platinum”).